Skip to main content

CAP TODAY/Celgene Webinar: Molecular Testing in AML: From Today to Tomorrow

Thank you

This live web event has ended. Thank you for attending.

Description



Molecular Testing in AML: From Today to Tomorrow

Why should you register now for this webinar?
Listen to national thought leaders discuss the importance of molecular
testing in Acute Myeloid Leukemia
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Pritish K. Bhattacharyya, MD

Learning Objectives:
Understand the complexity of AML
Learn the common mutations tested for in AML
Review Mutational Testing in 2017 CAP-ASH Guidelines
Discuss timeliness of testing results in AML
Ask questions of our distinguished presenter

Pursuant to PhRMA Code on Interactions with Healthcare Professionals, attendance at this promotional program is restricted to healthcare professionals. Accordingly, spouses and other guests who are not healthcare professionals may not attend this event. This is a promotional program and no CME credits are offered.

This is a Celgene sponsored promotional program. CAP TODAY does not endorse any of the products or services named within.
©2018 Celgene Corporation 01/18 US-CELG170225b

Contributors

  • Bob McGonnagle

    Publisher, CAP TODAY

  • Pritish K. Bhattacharyya, MD

    Director of Hematopathology & Molecular Pathology
    Hackensack University Medical Center, New Jersey

March 7, 2018
Wed 1:00 PM EST

Duration 1H 0M

This live web event has ended.

For Technical Support
+1 (858) 201-4136